A rating of 85 puts Marker Therapeutics Inc (MRKR) near the top of the Biotechnology industry according to InvestorsObserver. Marker Therapeutics Inc's score of 85 means it scores higher than 85% of stocks in the industry. Marker Therapeutics Inc also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 64 out of the 148 industries.
MRKR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on MRKR!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Marker Therapeutics Inc Stock Today?
Marker Therapeutics Inc (MRKR) stock is trading at $5.89 as of 10:04 AM on Tuesday, Sep 12, a loss of -$0.26, or -4.3% from the previous closing price of $6.15. The stock has traded between $5.75 and $6.30 so far today. Volume today is less active than usual. So far 6,699 shares have traded compared to average volume of 92,022 shares.
Click Here to get the full Stock Report for Marker Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
